|
|
|
Volumn 7, Issue 2, 1994, Pages 87-95
|
|
Potential clinical applications of CCK(A) receptor antagonists in gastroenterology
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA;
2 NAPHTHALENESULFONYLASPARTIC ACID N (2 PHENYLETHYL)AMIDE;
4 [[2 [2 [[(2 ADAMANTYLOXY)CARBONYL]AMINO] 3 (1H INDOL 3 YL) 2 METHYLPROPIONAMIDO] 1 PHENYLETHYL]AMINO] 4 OXOBUTYRIC ACID MEGLUMINE;
AMINO ACID DERIVATIVE;
ASPERLICIN;
BENZODIAZEPINE DERIVATIVE;
BENZOTRIPT;
CHOLECYSTOKININ;
CHOLECYSTOKININ A RECEPTOR;
CHOLECYSTOKININ B RECEPTOR;
CHOLECYSTOKININ DERIVATIVE;
CHOLECYSTOKININ RECEPTOR BLOCKING AGENT;
CHOLECYSTOKININ RECEPTOR STIMULATING AGENT;
CYCLIC NUCLEOTIDE;
DEVAZEPIDE;
DIBUTYRYL CYCLIC GMP;
LINTITRIPT;
LORGLUMIDE;
LOXIGLUMIDE;
LY 206890;
LY 262291;
N TERT BUTYLOXYCARBONYLTRYPTOPHYL[NEPSILON (2 METHYLPHENYLAMINOCARBONYL)LYSYL]ASPARTYL N METHYLPHENYLALANINAMIDE;
NATURAL PRODUCT;
PROGLUMIDE;
PYRAZOLONE DERIVATIVE;
RECEPTOR SUBTYPE;
SPIROGLUMIDE;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VIRGINIAMYCIN;
CLINICAL TRIAL;
DIGESTIVE SYSTEM CANCER;
GALLBLADDER;
GASTROENTEROLOGY;
GASTROINTESTINAL DISEASE;
HUMAN;
INTESTINE;
NONHUMAN;
PANCREAS;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
REVIEW;
STOMACH;
|
|
EID: 0028265131
PISSN: 02140934
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (17)
|
|
References (0)
|
